Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

The expression and evaluation of androgen receptor in human renal cell carcinoma.

Zhu G, Liang L, Li L, Dang Q, Song W, Yeh S, He D, Chang C.

Urology. 2014 Feb;83(2):510.e19-24. doi: 10.1016/j.urology.2013.10.022. Epub 2013 Dec 12.

PMID:
24332122
2.

Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors.

Langner C, Ratschek M, Rehak P, Schips L, Zigeuner R.

J Urol. 2004 Feb;171(2 Pt 1):611-4.

PMID:
14713771
3.
4.

Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.

Yu CP, Ho JY, Huang YT, Cha TL, Sun GH, Yu DS, Chang FW, Chen SP, Hsu RJ.

PLoS One. 2013;8(2):e56667. doi: 10.1371/journal.pone.0056667. Epub 2013 Feb 27.

5.

Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.

Breault JE, Shiina H, Igawa M, Ribeiro-Filho LA, Deguchi M, Enokida H, Urakami S, Terashima M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):557-64.

6.

Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR) → c-Myc signals.

Song W, Li L, He D, Xie H, Chen J, Yeh CR, Chang LS, Yeh S, Chang C.

Cancer Lett. 2015 Nov 1;368(1):71-8. doi: 10.1016/j.canlet.2015.07.027. Epub 2015 Jul 29.

PMID:
26231735
7.

The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.

Elsamman EM, Fukumori T, Tanimoto S, Nakanishi R, Takahashi M, Toida K, Kanayama HO.

BJU Int. 2006 Sep;98(3):668-73.

8.

Sprouty2 is associated with prognosis and suppresses cell proliferation and invasion in renal cell carcinoma.

Li P, Tao L, Yang J, Cai H, Ju X, Li J, Shao P, Cao Q, Qin C, Meng X, Yin C.

Urology. 2013 Jul;82(1):253.e1-7. doi: 10.1016/j.urology.2013.02.051. Epub 2013 May 17.

PMID:
23688375
9.

C1QBP Regulates YBX1 to Suppress the Androgen Receptor (AR)-Enhanced RCC Cell Invasion.

Yue D, Wang Y, Sun Y, Niu Y, Chang C.

Neoplasia. 2017 Feb;19(2):135-144. doi: 10.1016/j.neo.2016.12.003. Epub 2017 Jan 17.

10.

Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.

Kruck S, Hennenlotter J, Vogel U, Schilling D, Gakis G, Hevler J, Kuehs U, Stenzl A, Schwentner C.

BJU Int. 2012 Feb;109(4):634-8. doi: 10.1111/j.1464-410X.2011.10392.x. Epub 2011 Jun 28.

11.

Upregulation of GRP78 in renal cell carcinoma and its significance.

Fu W, Wu X, Li J, Mo Z, Yang Z, Huang W, Ding Q.

Urology. 2010 Mar;75(3):603-7. doi: 10.1016/j.urology.2009.05.007. Epub 2009 Jul 17.

PMID:
19616278
12.

Analysis of CD44 isoform v10 expression and its prognostic value in renal cell carcinoma.

Li N, Tsuji M, Kanda K, Murakami Y, Kanayama H, Kagawa S.

BJU Int. 2000 Mar;85(4):514-8.

13.

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.

PMID:
9199639
14.

Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Tickoo SK, dePeralta-Venturina MN, Harik LR, Worcester HD, Salama ME, Young AN, Moch H, Amin MB.

Am J Surg Pathol. 2006 Feb;30(2):141-53.

PMID:
16434887
15.

Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma.

Miyata Y, Kanda S, Sakai H, Greer PA.

Cancer Sci. 2013 Jun;104(6):681-6. doi: 10.1111/cas.12140. Epub 2013 Apr 18.

16.
17.

Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.

Bhuvarahamurthy V, Schroeder J, Kristiansen G, Roigas J, Denkert C, Johannsen M, Lein M, Loening SA, Schnorr D, Jung K, Staack A.

Oncol Rep. 2005 Sep;14(3):777-82.

PMID:
16077991
18.

Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma.

Fan L, Li P, Yin Z, Fu G, Liao DJ, Liu Y, Zhu J, Zhang Y, Wang L, Yan Q, Guo Y, Shao C, Huang G, Wang Z.

Br J Cancer. 2013 Sep 3;109(5):1137-46. doi: 10.1038/bjc.2013.463. Epub 2013 Aug 13.

19.

Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma.

Herrem CJ, Tatsumi T, Olson KS, Shirai K, Finke JH, Bukowski RM, Zhou M, Richmond AL, Derweesh I, Kinch MS, Storkus WJ.

Clin Cancer Res. 2005 Jan 1;11(1):226-31.

20.

[Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].

Li CY, Yao AM, Chang XN, Guo YH, Xu R.

Zhonghua Zhong Liu Za Zhi. 2013 Dec;35(12):897-903. Chinese.

PMID:
24506958

Supplemental Content

Support Center